期刊文献+

吸液缓溶性壬苯醇醚膜的急性毒性和致突变性研究 被引量:1

Study on the acute toxicity and mutagenicity of the imbibition slow solution nonoxynol-9 membrane
下载PDF
导出
摘要 目的研究吸液缓溶性壬苯醇醚膜的急性毒性和致突变性,为评价安全性提供毒理学依据。方法使用昆明种清洁级小鼠进行急性经口毒性实验,小鼠骨髓嗜多染红细胞微核试验和小鼠精子畸形实验。结果对小鼠的急性经口毒性试验,LD_(50)>5,000mg/kg体重,属于实际无毒物。小鼠骨髓嗜多染红细胞微核和小鼠精子畸形率实验结果均为阴性,无致微核作用和无致精子畸形作用。结论吸液缓溶性壬苯醇醚膜无急性毒性作用,对体细胞和生殖细胞无致突变性。 Objective: To study the acute toxicity and mutagenicity of the imbibitlon slow solution nonoxynol-u (NP-9) membrane for evaluating its security. Methods: Toxicological properties of the membranes were evaluated by acute toxicity test, the micro- nucleus tests with bone marrow polychromatic erythrocyte and sperm abnormality tests in Kunming mice. Results: LD50 of the imbibition slow solution NP-9 membranes in Kunming mice was more than 5000 mg/kg, bw, and no toxic effects were observed. The results of micronucleus test and sperm abnormality test were negative. Conclusions: The imbibition slow solution NP-9 membrane had no acute toxicity and mutagenic action on somatic cell and germ cell.
出处 《生殖医学杂志》 CAS 2012年第1期55-58,共4页 Journal of Reproductive Medicine
关键词 急性毒性 致突变性 吸液缓溶 壬苯醇醚-9 Toxicity Mutagenic Imbibition slow solution Nonoxinol-9
  • 相关文献

参考文献2

二级参考文献23

  • 1蔡钦生,冯美卿,黄海,周珮.生物芯片、基因组学和蛋白质组学在药物研发中的应用[J].药学学报,2003,38(10):795-800. 被引量:13
  • 2王全军,吴纯启,廖明阳.代谢物组学的研究进展[J].中国新药杂志,2004,13(9):776-780. 被引量:5
  • 3王全军,吴纯启,廖明阳.发现毒理学的研究进展[J].中国新药杂志,2005,14(8):958-961. 被引量:4
  • 4SANSEAU P. Impact of human genome sequencing for in silico larget diseovery[J]. Drug Discos, Today,2001,6(6) 316 -323.
  • 5VENKATAPATHY R, WANG CY, BRUCE R M. Chandrika Moudgal. Developmenl of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals 1. Alternative toxicity measures as an estimator of carcinogenic potency [ J ]. Toxicol Appl Pbarmacol, 2009. 234 ( 2 ) : 209 -221.
  • 6FENTEM JH, ARCHER GEB, BALLS M, et al. The ECVAM internaliutnal valiclalion sludy on In Vitro lesls for skin corrosivity. 2. Results and evaluation by the management team [J]. Toxicol in Vitro,1998,12(4) : 483 -524.
  • 7RAUSCH O. High content cellular screening[ J]. Curt Opin Chem Biol,2006,10(4) :316 -320.
  • 8TAYLOR DL,GIULIANO KA. Multiplexed high content screening assays create a systems cell biology, approach to drug d scovery[ J]. Drug Discovery Today Technologies,2005, 2(2) : 149 - 154.
  • 9KRAMER JA, SAGARTZ JE, MORRIS DL. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates[J]. Nat Rev Drug Discov,2007,6 (8): 636-649.
  • 10LUM PY, HE YD, SLATTER JG, et al. Gene expression profiling of rat liver reveals a mechanistic basis for ritonavir - induced hyperlipidemia [ J ]. Genomics ,2007,90 ( 4 ) :464 - 473.

共引文献8

同被引文献22

  • 1刘兴国.使用壬苯醇醚避孕药膜失败对胎婴的影响[J].生殖与避孕,1993,13(4):312-312. 被引量:4
  • 2蔡起航,胡培明,高清云,吴晓岚,陈嘉政.壬苯醇醚避孕药膜的临床研究[J].生殖与避孕,1989,9(4):48-53. 被引量:8
  • 3任磊,杨方纬,谢凤,刘佳,吴春莲,朱红梅,丁鑫,陆华.屏障避孕法的研究进展[J].现代医药卫生,2005,21(21):2929-2930. 被引量:4
  • 4王益鑫,任鸿娣,徐福忠,等.壬苯醇醚对人类精子作用的扫描电镜观察.生殖与避孕,1988,8:67.
  • 5龚向东,邵长庚.屏障避孕法、杀精剂与性传播疾病.国外医学皮肤性病学分册,1996,22:62-63.
  • 6Trusse11 J, Sturgen K, Strickler J, et al. Comparative contraceptive efficacy of the female condom and other barrier methods. Fam Plann Perspect, 1994,26 : 66.
  • 7Mauck CK, ALLen S, Baker JM, et al. An evaluation of the amount of nonoxynol-9 remaining in the vagina up to 4h after insertion of a vaginal contraceptive film (VCF) containing 70mg nonoxynol-9. Contraception, 1997,56 : 103.
  • 8Rosenstein IJ,Stafford MK,Kitchen VS, et al. Effect on normal Vaginal flora of three intravaginal mierobicidal agents potentially active against human immunodeficiency virus type I. J Infect Dis, 1998,177: 1386- 1390.
  • 9李建和,黎银波,崔魏,等.国外阴道给药系统的制剂开发与临床应用.中国药物应用与检测.2008,5:44-47,64.
  • 10Hicks DR, Martin LS, Getchell JP, et al. Inactivation of HTLV- III/LAV- infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. lancet, 1985,2 : 1422-1423.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部